company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-79129000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-79129000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11287000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,34771000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-56015000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-89086000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-89086000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-34857000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-581139000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,646861000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-50000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,30815000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,30815000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-200807000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7949000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-192858000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-192858000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-251129000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,9348000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 07:30:53+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3079000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36489000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36489000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4935000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10951000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-23507000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-44110000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-44110000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22316000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9331000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10233000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-50000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q4,2009-10-01,2009-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-21464000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-21464000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3972000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,18356000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,22328000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,22328000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q4,2009-10-01,2009-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-43246000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q4,2009-10-01,2009-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2525000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-67830000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-67830000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14247000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,33497000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-49850000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-69936000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-69936000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-97318000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-199997000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,295167000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2148000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2148000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8598000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,22765000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,31363000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,31363000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-40721000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,FY,2009-01-01,2009-12-31,2012-02-21 07:31:08+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,2525000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 07:33:17+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31341000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 07:33:17+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31341000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 07:33:17+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9312000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 07:33:17+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,22546000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 07:33:17+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-26343000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 07:33:17+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-25826000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 07:33:17+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-25826000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 07:33:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-75002000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 07:33:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-190666000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 07:33:17+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,284934000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 07:33:17+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,50000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 07:33:17+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,19316000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 07:33:17+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,19316000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 07:33:17+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 07:33:17+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4626000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 07:33:17+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4409000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 07:33:17+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9035000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 07:33:17+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9035000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-10-28 07:33:17+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2525000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1015000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1015000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3590000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7452000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-19849000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9822000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9822000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22331000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-85351000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,94211000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13471000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13471000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2921000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-773000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2148000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2148000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q3,2009-07-01,2009-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-21145000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-28 07:30:36+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30326000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-28 07:30:36+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30326000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-28 07:30:36+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5722000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-28 07:30:36+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15094000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-28 07:30:36+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6494000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-28 07:30:36+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16004000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-28 07:30:36+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16004000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-28 07:30:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-52671000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-28 07:30:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-105315000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-28 07:30:36+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,190723000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-28 07:30:36+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,50000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-28 07:30:36+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,32787000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-28 07:30:36+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,32787000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-28 07:30:36+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-28 07:30:36+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1705000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-28 07:30:36+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5182000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-28 07:30:36+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6887000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-28 07:30:36+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6887000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-07-28 07:30:36+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,23670000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14597000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14597000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6086000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15019000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-47359000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-40851000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-40851000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-32262000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-369400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,45240000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-354622000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-354622000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1028000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,47544000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,186828000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-50585000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,182759000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,182759000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-212714000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,12737000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-104468000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-104468000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,19687000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,43977000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,140026000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,99222000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,99222000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-99689000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-611065000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,273723000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-437031000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-437031000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1028000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,47544000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,200588000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-3798000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,243306000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,243306000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-94503000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 16:13:21+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,12737000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 07:31:02+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-89871000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 07:31:02+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-89871000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 07:31:02+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,13601000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 07:31:02+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,28958000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 07:31:02+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,187385000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 07:31:02+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,140073000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 07:31:02+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,140073000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 07:31:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-67427000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 07:31:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-241665000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 07:31:02+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,228483000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 07:31:02+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 07:31:02+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-82409000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 07:31:02+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-82409000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 07:31:02+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 07:31:02+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13760000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 07:31:02+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,46787000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 07:31:02+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,60547000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 07:31:02+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,60547000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-10-27 07:31:02+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,118211000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-126360000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-126360000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18536000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,39909000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,163878000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,95963000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,95963000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-89743000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-250996000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,238716000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1850000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-103873000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-103873000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,17732000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,65143000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,82875000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,82875000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3TTM,2009-10-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,74965000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3TTM,2009-10-01,2010-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2525000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33875000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33875000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4894000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9794000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,180688000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,161501000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,161501000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22103000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19497000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,91772000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,50172000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,50172000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1696000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-83000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1613000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1613000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,213286000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 07:30:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-55996000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 07:30:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-55996000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 07:30:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8707000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 07:30:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,19164000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 07:30:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6697000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 07:30:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21428000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 07:30:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21428000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 07:30:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-45324000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 07:30:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-222168000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 07:30:53+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,136711000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 07:30:53+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 07:30:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-132581000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 07:30:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-132581000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 07:30:53+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 07:30:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,12064000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 07:30:53+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,46870000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 07:30:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,58934000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 07:30:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,58934000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-07-28 07:30:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-95075000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-93500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-93500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,17232000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,37567000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-36659000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-75360000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-75360000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-89971000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-316850000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,241155000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1850000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-167516000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-167516000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,18957000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,64453000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,83410000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,83410000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2TTM,2009-07-01,2010-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-159466000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2TTM,2009-07-01,2010-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2525000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25474000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25474000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4524000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9786000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-686000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11850000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11850000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22581000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-44574000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,72775000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3820000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3820000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2838000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-119000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2719000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2719000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q2,2010-04-01,2010-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5311000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30522000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30522000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4183000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9378000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7383000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9578000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9578000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22743000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-177594000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,63936000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-136401000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-136401000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9226000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,46989000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,56215000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,56215000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-89764000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2010.0,Q1,2010-01-01,2010-03-31,2011-05-03 07:30:45+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-53443000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-53443000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7926000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,25227000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-30027000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-50317000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-50317000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11289000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-124445000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,101826000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-33908000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-33908000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-657000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,391107000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,97252000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-126262000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,361440000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,361440000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,277215000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,14725000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-221760000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-221760000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,31082000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,67909000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-18913000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-141682000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-141682000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-57217000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-240668000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,426356000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,128471000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,128471000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1667000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,391107000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,137387000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-142578000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,384249000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,384249000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,371038000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,FY,2011-01-01,2011-12-31,2014-02-13 16:07:14+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,14725000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 07:29:40+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-168317000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 07:29:40+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-168317000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 07:29:40+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,23156000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 07:29:40+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,42682000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 07:29:40+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,11114000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 07:29:40+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-91365000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 07:29:40+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-91365000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 07:29:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-45928000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 07:29:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-116223000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 07:29:40+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,324530000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 07:29:40+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,162379000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 07:29:40+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,162379000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 07:29:40+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1010000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 07:29:40+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,40135000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 07:29:40+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-16316000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 07:29:40+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,22809000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 07:29:40+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,22809000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-10-24 07:29:40+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,93823000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-182914000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-182914000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,29242000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,57701000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-36245000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-132216000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-132216000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-78190000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-485623000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,369770000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-192243000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-192243000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2038000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,47544000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,226963000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-66901000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,205568000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,205568000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-118891000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3TTM,2010-10-01,2011-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,12737000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-62365000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-62365000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8276000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,14653000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7299000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-46735000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-46735000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8898000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-99904000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,107899000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-903000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-903000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-306000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11634000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-11607000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-279000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-279000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-47917000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 07:00:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-105952000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 07:00:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-105952000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 07:00:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14880000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 07:00:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,28029000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 07:00:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,18413000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 07:00:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-44630000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 07:00:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-44630000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 07:00:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-37030000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 07:00:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16319000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 07:00:24+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,216631000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 07:00:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,163282000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 07:00:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,163282000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 07:00:24+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-704000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 07:00:24+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,28501000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 07:00:24+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-4709000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 07:00:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,23088000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 07:00:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,23088000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-07-25 07:00:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,141740000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-154424000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-154424000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,25860000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,52842000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,151742000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,76020000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,76020000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-91395000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-405216000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,353643000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-141168000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-141168000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1732000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,47544000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,217025000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-55377000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,207460000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,207460000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,142312000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2TTM,2010-07-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,12737000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-62505000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-62505000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,7902000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12646000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7907000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-34050000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-34050000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14864000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-681000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,158480000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,142935000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,142935000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-398000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,14095000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-3646000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10051000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10051000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,118936000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-43447000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-43447000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6978000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15383000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10506000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10580000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10580000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22166000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15638000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,58151000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,20347000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,20347000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-306000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,14406000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1063000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13037000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13037000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 07:31:17+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,22804000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-117393000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-117393000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,22482000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,49982000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,143149000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,98220000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,98220000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-99112000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-449109000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,267938000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-280283000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-280283000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1334000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,47544000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,205768000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-51850000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,200128000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,200128000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,18065000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2011.0,Q1TTM,2010-04-01,2011-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,12737000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,470407000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,470407000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9778000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,57101000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-444101000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,93185000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,93185000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15162000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-72174000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,178439000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,91103000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,91103000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-602000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,15109000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-87517000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-73010000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-73010000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,111278000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,21946000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,750269000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,750269000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,36940000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,151131000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1012955000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-74615000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-74615000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-49337000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-470945000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,439209000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-81073000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-81073000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2203000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,63549000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-158992000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-97646000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-97646000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-253334000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,21946000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,FY,2012-01-01,2012-12-31,2015-02-12 16:39:16+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-05 07:14:08+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,279862000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-05 07:14:08+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,279862000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-05 07:14:08+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,27162000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-05 07:14:08+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,94030000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-05 07:14:08+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-568854000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-05 07:14:08+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-167800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-05 07:14:08+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-167800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-05 07:14:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-34175000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-05 07:14:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-398771000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-05 07:14:08+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,260770000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-05 07:14:08+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-172176000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-05 07:14:08+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-172176000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-05 07:14:08+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1601000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-05 07:14:08+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,48440000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-05 07:14:08+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-71475000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-05 07:14:08+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-24636000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-05 07:14:08+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-24636000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-05 07:14:08+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-364612000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,226419000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,226419000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,35088000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,119257000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-598881000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-218117000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-218117000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-45464000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-523216000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,362596000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-206084000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-206084000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2258000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,391107000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,145692000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-197737000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,336804000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,336804000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-87397000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3TTM,2011-10-01,2012-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,14725000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,191468000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,191468000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9329000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,28933000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-232112000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2382000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2382000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10248000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-127395000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,88889000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-48754000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-48754000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-587000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8809000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-10031000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1809000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1809000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-52945000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 07:10:00+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,88394000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 07:10:00+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,88394000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 07:10:00+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,17833000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 07:10:00+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,65097000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 07:10:00+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-336742000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 07:10:00+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-165418000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 07:10:00+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-165418000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 07:10:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-23927000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 07:10:00+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-271376000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 07:10:00+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,171881000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 07:10:00+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-123422000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 07:10:00+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-123422000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 07:10:00+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1014000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 07:10:00+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,39631000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 07:10:00+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-61444000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 07:10:00+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-22827000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 07:10:00+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-22827000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 07:10:00+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-311667000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27414000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27414000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,34035000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,104977000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-374068000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-262470000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-262470000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-44114000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-495725000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,381606000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-158233000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-158233000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1977000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,391107000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,148517000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-199313000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,338334000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,338334000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-82369000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2TTM,2011-07-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,14725000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,76743000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,76743000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9417000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,33816000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-198353000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-78377000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-78377000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12872000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-222344000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,96028000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-139188000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-139188000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-514000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7803000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-12366000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5077000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5077000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-222642000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,11651000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11651000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8416000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,31281000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-138389000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-87041000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-87041000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11055000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-49032000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,75853000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,15766000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,15766000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,31828000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-49078000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-17750000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-17750000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 10:20:35+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-89025000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-166662000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-166662000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,32520000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,83807000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-167808000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-218143000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-218143000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-46106000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-274062000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,444058000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,123890000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,123890000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1861000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,391107000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,154809000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-190593000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,353462000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,353462000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,259209000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2012.0,Q1TTM,2011-04-01,2012-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,14725000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,413738000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,413738000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,41204000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,262128000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-128474000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,588596000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,588596000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-156323000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-577278000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,378146000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-355455000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-355455000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2024000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,57393000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,16822000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,72191000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,72191000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,305332000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,23197000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,FY,2013-01-01,2013-12-31,2016-02-11 16:45:24+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1057000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,86182000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,86182000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11292000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,85885000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,98370000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,281729000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,281729000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-68976000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-99966000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,58994000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-109948000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-109948000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-399000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,15675000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,85340000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,100616000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,100616000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,272397000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,23197000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1057000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,797963000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,797963000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,39690000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,233344000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-670945000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,400052000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,400052000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-102509000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-549486000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,497591000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-154404000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-154404000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2227000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,56827000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-156035000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-101435000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-101435000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,144213000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3TTM,2012-10-01,2013-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,21946000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,141306000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,141306000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10803000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,49132000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-108786000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,92455000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,92455000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-31691000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-194669000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11908000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-214452000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-214452000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-628000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7418000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-3257000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3533000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3533000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-118464000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-04 07:06:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,327556000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-04 07:06:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,327556000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-04 07:06:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,29912000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-04 07:06:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,176243000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-04 07:06:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-226844000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-04 07:06:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,306867000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-04 07:06:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,306867000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-04 07:06:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-87347000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-04 07:06:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-477312000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-04 07:06:24+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,319152000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-04 07:06:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-245507000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-04 07:06:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-245507000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-04 07:06:24+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1625000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-04 07:06:24+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-04 07:06:24+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,41718000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-04 07:06:24+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-68518000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-04 07:06:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-28425000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-04 07:06:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-28425000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-11-04 07:06:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,32935000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,848125000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,848125000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,38216000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,213145000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-794271000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,305215000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,305215000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-81066000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-482212000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,574572000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11294000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11294000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2186000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,58218000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-162809000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-106777000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-106777000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,209732000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2TTM,2012-07-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,21946000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,87376000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,87376000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9702000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,61126000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-30040000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,128164000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,128164000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-34453000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-101407000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,252490000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,116630000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,116630000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-348000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,21336000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-64469000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-43481000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-43481000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,201313000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 06:52:44+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,186250000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 06:52:44+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,186250000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 06:52:44+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,19109000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 06:52:44+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,127111000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 06:52:44+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-118058000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 06:52:44+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,214412000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 06:52:44+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,214412000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 06:52:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-55656000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 06:52:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-282643000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 06:52:44+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,307244000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 06:52:44+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-31055000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 06:52:44+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-31055000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 06:52:44+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-997000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 06:52:44+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 06:52:44+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,34300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 06:52:44+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-65261000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 06:52:44+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-31958000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 06:52:44+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-31958000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-05 06:52:44+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,151399000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,98874000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,98874000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9407000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,65985000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-88018000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,86248000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,86248000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21203000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-181236000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,54754000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-147685000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-147685000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-649000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,12964000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-792000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,11523000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11523000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:57:11+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-49914000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,837492000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,837492000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,37931000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,185835000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-962584000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,98674000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,98674000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-59485000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-603149000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,418110000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-244524000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-244524000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2352000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,44685000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-110706000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-68373000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-68373000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-214223000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2013.0,Q1TTM,2012-04-01,2013-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,21946000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,338126000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,338126000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,52686000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,399321000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-37698000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,752435000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,752435000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-333006000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-564188000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,476417000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-420777000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-420777000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-221734000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-294552000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,126045000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,171694000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-218547000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-218547000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,113111000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,20348000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,FY,2014-01-01,2014-12-31,2017-02-09 16:05:36+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,59847000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,90095000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,90095000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14135000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,151329000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-57384000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,198175000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,198175000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-117542000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-85752000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,259939000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,56645000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,56645000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-159799000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-151511000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,45241000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,13414000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-252655000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-252655000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2165000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,20348000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,59847000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 07:24:05+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,248031000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 07:24:05+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,248031000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 07:24:05+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,38551000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 07:24:05+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,247992000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 07:24:05+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,19686000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 07:24:05+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,554260000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 07:24:05+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,554260000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 07:24:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-215464000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 07:24:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-478436000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 07:24:05+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,216478000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 07:24:05+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-477422000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 07:24:05+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-477422000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 07:24:05+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-61935000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 07:24:05+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-143041000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 07:24:05+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,80804000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 07:24:05+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,158280000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 07:24:05+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,34108000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 07:24:05+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,34108000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-11-04 07:24:05+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,110946000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,334213000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,334213000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,49843000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,333877000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,118056000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,835989000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,835989000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-284440000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-578402000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,275472000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-587370000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-587370000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-62334000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-143041000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,96479000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,243620000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,134724000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,134724000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,383343000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,23197000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3TTM,2013-10-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1057000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,83375000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,83375000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14005000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,79123000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12182000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,164321000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,164321000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-79769000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-103927000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,60628000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-123068000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-123068000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-276000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,17747000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-12305000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5166000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5166000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,46419000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,392144000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,392144000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,46641000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,303886000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,21452000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,764123000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,764123000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-236362000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-669144000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,226752000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-678754000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-678754000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-62686000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-143041000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,86150000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,252668000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,133091000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,133091000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,218460000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,23197000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2TTM,2013-07-01,2014-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1057000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,96351000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,96351000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,13016000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,83407000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,143638000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,336412000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,336412000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-70873000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-120631000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,73381000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-118123000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-118123000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-61397000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-143041000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8015000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,116411000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-80012000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-80012000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,138277000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 07:21:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,164656000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 07:21:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,164656000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 07:21:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,24546000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 07:21:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,168869000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 07:21:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,31868000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 07:21:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,389939000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 07:21:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,389939000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 07:21:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-135695000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 07:21:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-374509000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 07:21:24+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,155850000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 07:21:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-354354000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 07:21:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-354354000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 07:21:24+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-61659000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 07:21:24+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-143041000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 07:21:24+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,63057000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 07:21:24+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,170585000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 07:21:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,28942000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 07:21:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,28942000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-08-04 07:21:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,64527000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,383169000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,383169000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,43327000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,281605000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-152226000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,555875000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,555875000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-199942000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-649920000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,405861000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-444001000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-444001000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1637000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,99471000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,71788000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,169622000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,169622000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,281496000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,23197000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1TTM,2013-04-01,2014-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1057000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,68305000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,68305000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11530000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,85462000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-111770000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,53527000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,53527000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-64822000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-253878000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,82469000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-236231000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-236231000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-262000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,55042000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,54174000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,108954000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,108954000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:30:44+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-73750000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,636056000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,636056000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,74909000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,511611000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,108204000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1330780000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1330780000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-677933000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-557105000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,327437000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-907601000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-907601000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-167853000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-573487000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,27373000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,206358000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,244780000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-262829000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-262796000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,160383000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,10582000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:22:58+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,276092000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,154994000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,154994000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,22910000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,176035000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-72116000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,281823000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,281823000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-177779000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6963000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,61442000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-123300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-123300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-4008000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,154515000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,10582000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,276092000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-04 07:32:27+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,481062000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-04 07:32:27+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,481062000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-04 07:32:27+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,51999000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-04 07:32:27+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,335576000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-04 07:32:27+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,180320000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-04 07:32:27+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1048957000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-04 07:32:27+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1048957000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-04 07:32:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-500154000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-04 07:32:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-550142000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-04 07:32:27+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,265995000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-04 07:32:27+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-784301000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-04 07:32:27+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-784301000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-04 07:32:27+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-146007000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-04 07:32:27+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-523487000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-04 07:32:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,26405000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-04 07:32:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,150423000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-04 07:32:27+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,233878000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-04 07:32:27+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-258788000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-04 07:32:27+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-258788000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-11-04 07:32:27+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5868000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,571157000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,571157000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,66134000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,486905000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,122936000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1247132000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1247132000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-617696000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-635894000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,525934000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-727656000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-727656000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-305806000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-674998000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,26405000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,195664000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,247292000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-511443000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-511443000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8033000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,20348000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3TTM,2014-10-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,59847000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,210398000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,210398000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,20674000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,104543000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,557238000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,892853000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,892853000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-146099000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-209298000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,72226000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-283171000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-283171000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2006000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-398956000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-375000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,34598000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,21090000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-345649000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-345649000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,264033000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-04 07:31:35+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,270664000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-04 07:31:35+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,270664000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-04 07:31:35+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,31325000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-04 07:31:35+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,231033000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-04 07:31:35+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-376918000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-04 07:31:35+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,156104000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-04 07:31:35+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,156104000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-04 07:31:35+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-354055000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-04 07:31:35+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-340844000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-04 07:31:35+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,193769000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-04 07:31:35+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-501130000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-04 07:31:35+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-501130000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-04 07:31:35+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-144001000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-04 07:31:35+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-124531000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-04 07:31:35+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,26780000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-04 07:31:35+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,115825000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-04 07:31:35+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,212788000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-04 07:31:35+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,86861000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-04 07:31:35+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,86861000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-08-04 07:31:35+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-258165000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,444134000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,444134000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,59465000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,461485000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-446484000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,518600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,518600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-551366000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-530523000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,514336000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-567553000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-567553000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-304076000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-276042000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,26780000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,178813000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,213897000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-160628000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-160628000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-209581000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,20348000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2TTM,2014-07-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,59847000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,194643000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,194643000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15298000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,118466000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-70576000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,257831000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,257831000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-239893000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-245069000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,113313000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-371649000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-371649000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-127315000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,20042000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,39552000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,64186000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3535000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3535000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-117353000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,76021000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,76021000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16027000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,112567000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-306342000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-101727000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-101727000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-114162000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-95775000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,80456000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-129481000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-129481000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-16686000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-124531000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6738000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,76273000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,148602000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,90396000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,90396000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:35:22+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-140812000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,345842000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,345842000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,57183000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,426426000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-232270000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,597181000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,597181000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-382346000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-406085000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,474404000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-314027000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-314027000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-238158000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-419083000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6738000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,147276000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,266122000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-237105000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-237105000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,46049000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,20348000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2015.0,Q1TTM,2014-04-01,2015-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,59847000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,895522000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,895522000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,104745000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,605017000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-131888000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1473396000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1473396000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-511941000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-809419000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,274456000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1046904000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1046904000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-45668000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-643365000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5085000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,126739000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-143182000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-700391000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-700391000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-273899000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,5454000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,FY,2016-01-01,2016-12-31,2018-02-08 16:22:58+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,481360000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,253115000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,253115000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,28900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,186111000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-90247000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,377879000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,377879000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-150455000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-203266000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,82365000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-271356000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-271356000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-31165000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-401248000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,36962000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-96228000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-491679000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-491679000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-385156000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,5454000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q4,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,481360000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-08 07:54:13+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,642407000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-08 07:54:13+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,642407000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-08 07:54:13+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,75845000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-08 07:54:13+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,418906000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-08 07:54:13+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-41641000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-08 07:54:13+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1095517000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-08 07:54:13+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1095517000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-08 07:54:13+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-361486000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-08 07:54:13+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-606153000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-08 07:54:13+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,192091000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-08 07:54:13+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-775548000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-08 07:54:13+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-775548000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-08 07:54:13+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-14503000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-08 07:54:13+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-242117000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-08 07:54:13+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5085000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-08 07:54:13+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,89777000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-08 07:54:13+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-46954000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-08 07:54:13+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-208712000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-08 07:54:13+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-208712000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-11-08 07:54:13+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,111257000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,797401000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,797401000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,98755000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,594941000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-113757000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1377340000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1377340000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-539265000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-613116000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,253533000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-898848000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-898848000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-36349000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-292117000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6053000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,145712000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-36052000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-212753000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-212720000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,265772000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,10582000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3TTM,2015-10-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,276092000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,264804000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,264804000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,27839000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,137170000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,221216000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,651029000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,651029000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-118556000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-377211000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,89914000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-405853000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-405853000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-640000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5085000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,26171000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1941000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,28675000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,28675000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,273851000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-03 07:46:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,377603000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-03 07:46:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,377603000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-03 07:46:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,48006000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-03 07:46:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,281736000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-03 07:46:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-262857000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-03 07:46:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,444488000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-03 07:46:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,444488000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-03 07:46:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-242930000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-03 07:46:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-228942000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-03 07:46:53+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,102177000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-03 07:46:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-369695000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-03 07:46:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-369695000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-03 07:46:53+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-13863000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-03 07:46:53+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-242117000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-03 07:46:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,63606000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-03 07:46:53+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-45013000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-03 07:46:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-237387000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-03 07:46:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-237387000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-08-03 07:46:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-162594000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,742995000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,742995000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,91590000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,562314000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,222265000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1619164000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1619164000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-566808000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-445203000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,235845000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-776166000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-776166000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-37715000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-691073000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,593000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,154139000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-13021000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-587077000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-587044000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,255954000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,10582000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2TTM,2015-07-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,276092000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,196218000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,196218000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,25029000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,135529000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,42723000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,399499000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,399499000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-138836000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-228942000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,41768000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-326010000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-326010000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-11526000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,24302000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-43971000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-31195000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-31195000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,42294000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,181385000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,181385000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,22977000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,146207000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-305580000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,44989000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,44989000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-104094000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,60409000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-43685000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-43685000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2337000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-242117000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,39304000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1042000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-206192000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-206192000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 07:43:33+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-204888000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,741420000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,741420000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,81859000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,545251000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,108966000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1477496000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1477496000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-667865000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-461330000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,307390000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-821805000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-821805000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-153504000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-691073000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,20635000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,169389000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,95136000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-559417000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-559384000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,96307000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,10582000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2016.0,Q1TTM,2015-04-01,2016-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,276092000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1198500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1198500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,145500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,570800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-607700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1307100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1307100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-272600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1277200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,544600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1005200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1005200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-19900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,57000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,240200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-301700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-24400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-24400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,277500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,18700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,FY,2017-01-01,2017-12-31,2020-02-07 09:04:34+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,754800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,173508000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,173508000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,34540000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,146640000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,212249000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,566937000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,566937000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-107637000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-393452000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,165325000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-335764000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-335764000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,25000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13308000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-223868000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-210535000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-210535000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,20638000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,18700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,754800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 07:56:51+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1024992000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 07:56:51+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1024992000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 07:56:51+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,110960000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 07:56:51+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,424160000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 07:56:51+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-819949000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 07:56:51+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,740163000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 07:56:51+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,740163000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 07:56:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-164963000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 07:56:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-883748000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 07:56:51+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,379275000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 07:56:51+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 07:56:51+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-669436000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 07:56:51+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-669436000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 07:56:51+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-19925000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 07:56:51+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 07:56:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,57000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 07:56:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,226892000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 07:56:51+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-77832000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 07:56:51+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,186135000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 07:56:51+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,186135000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-11-06 07:56:51+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,256862000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1278107000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1278107000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,139860000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,610271000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-910196000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1118042000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1118042000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-315418000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1087014000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,461640000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-940792000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-940792000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-51090000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-401248000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,57000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,263854000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-174060000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-305544000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-305544000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-128294000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,5454000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3TTM,2016-10-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,481360000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,388317000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,388317000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,37719000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,131482000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-142686000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,414832000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,414832000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-59653000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-406340000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,107109000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-358884000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-358884000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,38199000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-46395000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-8196000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-8196000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,47752000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-02 16:11:08+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,636675000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-02 16:11:08+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,636675000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-02 16:11:08+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,73241000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-02 16:11:08+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,292678000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-02 16:11:08+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-677263000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-02 16:11:08+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,325331000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-02 16:11:08+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,325331000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-02 16:11:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-105310000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-02 16:11:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-477408000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-02 16:11:08+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,272166000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-02 16:11:08+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-310552000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-02 16:11:08+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-310552000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-02 16:11:08+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-19925000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-02 16:11:08+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,57000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-02 16:11:08+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,188693000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-02 16:11:08+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-31437000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-02 16:11:08+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,194331000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-02 16:11:08+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,194331000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-08-02 16:11:08+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,209110000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1154594000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1154594000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,129980000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,615959000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-546294000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1354239000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1354239000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-374321000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1057885000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,444445000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-987761000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-987761000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-51730000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-401248000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,62085000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,251826000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-129606000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-268673000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-268673000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,97805000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,5454000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2TTM,2016-07-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,481360000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,387744000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,387744000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,35126000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,154933000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-608373000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-30570000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-30570000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-54849000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-268714000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,153154000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-170409000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-170409000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-7064000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,172020000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-31437000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,133519000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,133519000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-67460000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,248931000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,248931000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,38115000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,137745000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-68890000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,355901000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,355901000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-50461000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-208694000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,119012000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-140143000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-140143000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-12861000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,57000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,16673000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,60812000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,60812000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,276570000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,963068000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,963068000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,119883000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,596555000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,104802000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1784308000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1784308000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-458308000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1018113000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,333059000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1143362000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1143362000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-56192000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-401248000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,62085000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,104108000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-142140000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-433387000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-433387000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,207559000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,5454000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2017.0,Q1TTM,2016-04-01,2017-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,481360000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2444400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2444400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,148200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,439500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-837000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2195100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2195100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-383100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1845500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,775600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-10000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1463000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1463000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-4400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,114500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-187200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-77100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-77100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,655000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,22300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,FY,2018-01-01,2018-12-31,2020-02-07 09:04:34+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,205600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,820400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,820400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,42800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,221500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-355900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,728800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,728800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-85500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-311900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,131500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-265900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-265900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,27100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-110100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-83000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-83000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,379900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,22300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,205600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-05 07:47:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1624000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-05 07:47:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1624000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-05 07:47:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,105400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-05 07:47:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,218000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-05 07:47:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-481100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-05 07:47:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1466300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-05 07:47:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1466300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-05 07:47:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-297600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-05 07:47:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1533600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-05 07:47:53+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,644100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-05 07:47:53+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-10000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-05 07:47:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1197100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-05 07:47:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1197100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-05 07:47:53+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-4400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-05 07:47:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,87400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-05 07:47:53+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-77100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-05 07:47:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-05 07:47:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-11-05 07:47:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,275100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1797508000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1797508000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,139940000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,364640000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-268851000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2033237000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2033237000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-405237000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1927052000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,809425000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-10000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1532864000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1532864000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,25000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-4400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,100708000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-300968000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-204635000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-204635000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,295738000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,18700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3TTM,2017-10-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,754800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,594608000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,594608000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,35400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,83763000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-260779000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,452992000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,452992000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-106208000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-352395000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,181888000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-10000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-286715000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-286715000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-4400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,53327000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-45247000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3680000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3680000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,169957000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,2018-08-02 16:11:08+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1029392000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,2018-08-02 16:11:08+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1029392000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,2018-08-02 16:11:08+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,70000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,2018-08-02 16:11:08+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,134237000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,2018-08-02 16:11:08+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-220321000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,2018-08-02 16:11:08+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1013308000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,2018-08-02 16:11:08+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1013308000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,2018-08-02 16:11:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-191392000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,2018-08-02 16:11:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1181205000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,2018-08-02 16:11:08+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,462212000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,2018-08-02 16:11:08+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-910385000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,2018-08-02 16:11:08+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-910385000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,2018-08-02 16:11:08+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,2018-08-02 16:11:08+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,2018-08-02 16:11:08+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,34073000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,2018-08-02 16:11:08+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-31853000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,2018-08-02 16:11:08+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2220000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,2018-08-02 16:11:08+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2220000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2YTD,2018-01-01,2018-06-30,2018-08-02 16:11:08+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,105143000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1591217000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1591217000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,142259000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,412359000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-150758000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1995077000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1995077000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-358682000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1980997000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,734646000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1605033000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1605033000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,25000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,85580000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-302116000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-216511000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-216511000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,173533000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,18700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2TTM,2017-07-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,754800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,551392000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,551392000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,33600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,47637000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-238521000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,394108000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,394508000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-111992000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-579905000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,206912000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-484985000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-484985000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,20673000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-31853000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-11180000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-11180000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-101657000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,478000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,478000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,36400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,86600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,18200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,619200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,618800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-79400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-601300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,255300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-425400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-425400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 07:50:15+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,206800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1427569000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1427569000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,143785000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,519655000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-520610000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1570399000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1569999000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-301539000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1669806000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,680888000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1290457000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1290457000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-7039000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,236927000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-301700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-71812000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-71812000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,207730000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,18700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2018.0,Q1TTM,2017-04-01,2018-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,754800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,792000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,792000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,54300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-9000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-49900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,787400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,787400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-139000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-367500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,297800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-208700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-208700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-246500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,48300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-147500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-345700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-345700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,233000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,25000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q4,2019-10-01,2019-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,342300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2115800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2115800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,210300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,435000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-331100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2430000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2430000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-429600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3202400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1604200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2027800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2027800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-275900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,211800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-188000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-252100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-252100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,150100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,25000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,FY,2019-01-01,2019-12-31,2020-02-07 09:04:34+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,342300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2144200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2144200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,198800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,665500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-637100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2371400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2371400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-376100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3146800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1437900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2085000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2085000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-29400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,190600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-150600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,297000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,22300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3TTM,2018-10-01,2019-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,205600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-05 07:47:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1323800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-05 07:47:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1323800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-05 07:47:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,156000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-05 07:47:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,444000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-05 07:47:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-281200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-05 07:47:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1642600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-05 07:47:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1642600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-05 07:47:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-290600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-05 07:47:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2834900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-05 07:47:53+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1306400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-05 07:47:53+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-05 07:47:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1819100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-05 07:47:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1819100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-05 07:47:53+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-29400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-05 07:47:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,163500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-05 07:47:53+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-40500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-05 07:47:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,93600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-05 07:47:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,93600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-11-05 07:47:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-82900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,669600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,669600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,52900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,119600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-284800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,557300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,557300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-121700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-645800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,560500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-207000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-207000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-19400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-11000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-11000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,339300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 07:55:20+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,654200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 07:55:20+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,654200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 07:55:20+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,103100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 07:55:20+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,324400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 07:55:20+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 07:55:20+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1085300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 07:55:20+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1085300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 07:55:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-168900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 07:55:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2189100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 07:55:20+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,745900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 07:55:20+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1612100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 07:55:20+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1612100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 07:55:20+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-10000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 07:55:20+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,155100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 07:55:20+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-40500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 07:55:20+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,104600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 07:55:20+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,104600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-08-06 07:55:20+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-422200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2069208000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2069208000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,181300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,629663000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-613079000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2267092000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2267092000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-360608000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2853395000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1059288000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-10000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2164715000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2164715000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-14400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,235527000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-195847000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,25280000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,25280000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,127657000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,22300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2TTM,2018-07-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,205600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,193100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,193100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,52100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,240300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-297200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,188300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,188300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-94600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1148900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,407500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-836000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-836000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,14500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-29800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-15300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-15300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-663000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,461100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,461100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,51000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,84100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,300800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,897000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,897000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-74300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1040200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,338400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-776100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-776100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-10000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,140600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-10700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,119900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,119900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 07:51:29+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,240800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2427500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2427500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,162800000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,437000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-554400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2472900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2473300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-378000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2284400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,858700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-10000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1813700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1813700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-14400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,241700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-197900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,29400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,29400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,689000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,22300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2019.0,Q1TTM,2018-04-01,2019-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,205600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2279300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2279300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,215400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,539300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-803000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2231000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2231000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-525400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2876500000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1707000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1694900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1694900000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-586600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,882600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-332400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-36400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-36400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,499700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,25000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1TTM,2019-04-01,2020-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,342300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,624600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,624600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,56100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,188400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-171100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,698000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,698000000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-170100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-714300000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,441200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-443200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-443200000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-320700000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,811400000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-155100000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,335600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,335600000.0
Regeneron Pharmaceuticals Inc,REGN,549300RCBFWIRX3HYQ56,0000872589,2020.0,Q1,2020-01-01,2020-03-31,2020-05-05 07:51:29+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,590400000.0
